524723 — Arvaya Healthcare Income Statement
0.000.00%
- IN₹4.75bn
- IN₹5.19bn
- IN₹91.13m
Annual income statement for Arvaya Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 3 | 2.8 | 2.79 | 91.1 |
| Cost of Revenue | ||||
| Gross Profit | 0.819 | 0.652 | 0.599 | 78.5 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 8.8 | 6.94 | 8.27 | 90 |
| Operating Profit | -5.81 | -4.14 | -5.48 | 1.08 |
| Total Net Non Operating Interest Income / Expense | ||||
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -4.45 | -1.17 | 1.91 | 10.9 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -4.44 | -1.17 | 1.36 | 9.04 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -4.44 | -1.17 | 1.36 | 7.02 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -4.44 | -1.17 | 1.36 | 9.04 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -1.48 | -0.565 | -0.757 | 0.892 |